<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03149471</url>
  </required_header>
  <id_info>
    <org_study_id>ENOPAT_PE</org_study_id>
    <nct_id>NCT03149471</nct_id>
  </id_info>
  <brief_title>The Role of Endothelial Function Test in Risk Stratification for Early and Late Complications After Pulmonary Embolism</brief_title>
  <official_title>The Role of Endothelial Function Test in Risk Stratification for Early and Late Complications After Pulmonary Embolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the association between endothelial dysfunction,
      measured by RHI as assessed by the peripheral arterial tonometry method, and PE complications
      defined as re-event of PE or DVT, systemic embolism or all-cause mortality
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      200 Patients will be identified through routine daily scanning of imaging records (CT,
      Echocardiography) for patients diagnosed with PE. Presenting signs and symptoms as well as
      clinical and imaging findings during the initial presentation and hospitalization will be
      incorporated into a computerized pre-specified electronic CRF. During hospitalization, an
      endothelial function test will be performed 48 hours post admission. A trained technician
      will perform the test using the EndoPAT device in order to assess patient RHI, a score less
      than 1.67 will be considerate as endothelial dysfunction. Patients will then be followed for
      pre-specified clinical events of up to 1 year post discharge and especially the development
      of chronic thromboembolic pulmonary disease, post thrombotic syndrome and clinical events.
      RHI will be assessed during 1-year follow up visit.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2017</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Post PE complications</measure>
    <time_frame>2 years</time_frame>
    <description>The aim of this study is to investigate the association between endothelial dysfunction, measured by RHI as assessed by the peripheral arterial tonometry method, and PE complications defined as re-event of PE or DVT, systemic embolism or all-cause mortality</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Augmentation Index (AI)</measure>
    <time_frame>2 years</time_frame>
    <description>To investigate the association between arterial stiffness as measured by Augmentation Index and post PE complications.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HRV</measure>
    <time_frame>2 years</time_frame>
    <description>To investigate the association between Heart Rate Variability and post PE complications.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemistry</measure>
    <time_frame>2 years</time_frame>
    <description>To assess the association between troponin levels to post PE complications</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Normal endothelial function</arm_group_label>
    <description>patients diagnosed with PE and have normal endothelial function test- RHI score &gt;=1.67</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Endothelial dysfunction group</arm_group_label>
    <description>patients diagnosed with PE and have endothelial function- RHI&lt;1.67</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Endothelial dysfunction test</intervention_name>
    <description>The endothelial function test will be assessed after 48 hours post admission and 1 year post discharge using the non-invasive Endo-PAT2000 device. The device is intended for use as a diagnostic aid in the detection of coronary artery endothelial dysfunction (positive or negative) using a reactive hyperemia procedure. It is based on the use of Peripheral Arterial Tone (PAT) signal technology, during a clinically established procedure, which measure post-ischemic vascular responsiveness following upper arm blood flow occlusion.</description>
    <arm_group_label>Normal endothelial function</arm_group_label>
    <arm_group_label>Endothelial dysfunction group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        250 Stable patients hospitalized in ICCU or Cardiology department with a diagnosis of acute
        PE according to CT scanning or nuclear imaging
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt;18 years old

          2. Patient is hospitalized with the diagnosis of acute PE

          3. Clinically stable patients.

          4. Clinical diagnosis of PE based on CT scan or nuclear imaging.

          5. Willing and able to sign informed consent

        Exclusion Criteria:

          1. Previous myocardial infarction during the last 3 months.

          2. Planned surgery or PCI.

          3. Inability to perform endothelial function test.

          4. Current participation in clinical trial.

          5. Substrate or drug abuse or alcohol consumption.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nir Shlomo, MSc</last_name>
    <phone>052-7205057</phone>
    <email>nir.shlomo@sheba.health.gov.il</email>
  </overall_contact>
  <reference>
    <citation>Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):370-2. doi: 10.1161/ATVBAHA.108.162545. Review.</citation>
    <PMID>18296591</PMID>
  </reference>
  <reference>
    <citation>Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M; VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007 Oct;98(4):756-64.</citation>
    <PMID>17938798</PMID>
  </reference>
  <reference>
    <citation>Goldhaber SZ. Venous thromboembolism: epidemiology and magnitude of the problem. Best Pract Res Clin Haematol. 2012 Sep;25(3):235-42. doi: 10.1016/j.beha.2012.06.007. Epub 2012 Aug 9. Review.</citation>
    <PMID>22959540</PMID>
  </reference>
  <reference>
    <citation>Centers for Disease Control and Prevention (CDC). Venous thromboembolism in adult hospitalizations - United States, 2007-2009. MMWR Morb Mortal Wkly Rep. 2012 Jun 8;61(22):401-4.</citation>
    <PMID>22672974</PMID>
  </reference>
  <reference>
    <citation>Heit JA, Silverstein MD, Mohr DN, Petterson TM, Lohse CM, O'Fallon WM, Melton LJ 3rd. The epidemiology of venous thromboembolism in the community. Thromb Haemost. 2001 Jul;86(1):452-63.</citation>
    <PMID>11487036</PMID>
  </reference>
  <reference>
    <citation>Becattini C, Cohen AT, Agnelli G, Howard L, Castejón B, Trujillo-Santos J, Monreal M, Perrier A, Yusen RD, Jiménez D. Risk Stratification of Patients With Acute Symptomatic Pulmonary Embolism Based on Presence or Absence of Lower Extremity DVT: Systematic Review and Meta-analysis. Chest. 2016 Jan;149(1):192-200. doi: 10.1378/chest.15-0808. Epub 2016 Jan 6. Review.</citation>
    <PMID>26204122</PMID>
  </reference>
  <reference>
    <citation>Cohen AT, Dobromirski M, Gurwith MM. Managing pulmonary embolism from presentation to extended treatment. Thromb Res. 2014 Feb;133(2):139-48. doi: 10.1016/j.thromres.2013.09.040. Epub 2013 Oct 14. Review.</citation>
    <PMID>24182642</PMID>
  </reference>
  <reference>
    <citation>Axtell AL, Gomari FA, Cooke JP. Assessing endothelial vasodilator function with the Endo-PAT 2000. J Vis Exp. 2010 Oct 15;(44). pii: 2167. doi: 10.3791/2167.</citation>
    <PMID>20972417</PMID>
  </reference>
  <reference>
    <citation>Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol. 2004 Dec 7;44(11):2137-41.</citation>
    <PMID>15582310</PMID>
  </reference>
  <reference>
    <citation>Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):168-75. Review.</citation>
    <PMID>12588755</PMID>
  </reference>
  <reference>
    <citation>Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000 Nov 10;87(10):840-4. Review.</citation>
    <PMID>11073878</PMID>
  </reference>
  <reference>
    <citation>Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000 Mar 7;101(9):948-54.</citation>
    <PMID>10704159</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 20, 2017</study_first_submitted>
  <study_first_submitted_qc>May 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2017</study_first_posted>
  <last_update_submitted>May 9, 2017</last_update_submitted>
  <last_update_submitted_qc>May 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sheba Medical Center</investigator_affiliation>
    <investigator_full_name>Dr. Shlomi Matetzky</investigator_full_name>
    <investigator_title>Director , Cardiac Intensive Care Unit</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Pulmonary Embolism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No IPD plan</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

